publications-banner
Information about pipeline products
The content contained is subject to congress/journal copyright permissions. No further reproduction is permitted without permission of the copyright owner.
Information about pipeline compounds or investigational uses of compounds does not imply FDA approval for these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the pipeline compounds or investigational uses will receive FDA approval. Daiichi Sankyo does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling.
PublicationView
T-DXd
Global study on the accuracy of human epidermal growth factor receptor 2-low diagnosis in breast cancer
T-DXd
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): Primary results from a multicentre, randomised, phase 2 trial
T-DXd
Trastuzumab deruxtecan in human epidermal growth factor receptor 2-expressing biliary tract cancer (HERB; NCCH1805): A multicenter, single-arm, phase II trial
HER3-DXd
Real-world treatment patterns and clinical outcomes among patients with metastatic or unresectable EGFR-mutated non-small cell lung cancer previously treated with osimertinib and platinum-based chemotherapy
Valemetostat
Population pharmacokinetics of total and unbound valemetostat and platelet dynamics in healthy volunteers and patients with non-Hodgkin lymphoma
Edoxaban
Patient outcomes in very elderly patients with non-valvular atrial fibrillation - ANAFIE Registry -
Edoxaban
Venous thromboembolism in patients undergoing surgery for lung cancer: A post hoc analysis of the Cancer-VTE Registry
Pexidartinib
TURALIO® Risk Evaluation and Mitigation Strategy Program (tREMS): 3-year retrospective hepatic safety assessment
Edoxaban
Risk factors of ischemic stroke in patients with atrial fibrillation after transcatheter aortic valve implantation from the randomized ENVISAGE-TAVI AF trial
Edoxaban
Clinical effects of direct oral anticoagulants in elderly patients with a bioprosthetic valve and atrial fibrillation